Special Spotlight On Diabetes Prescription Drugs: Byetta (exenatide)

Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission …

Special Spotlight On Diabetes Prescription Drugs: Basaglar

Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD.  Republished with permission …

FDA Approves First Oral Formulation of Semaglutide For Adults with T2D

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2 …

Swiss Drugmaker Halts Distribution of Zantac Worldwide

Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global …

Health Insurer Introduces Insulin Cost Relief Program in North Dakota

A Minnesota based health insurer, Medica, announced today it will expand its cap on the maximum amount members in North Dakota will pay for their …

Glytec Develops New Solution for Selection and Dosing Diabetes Medications

Less than half of the estimated 22 million people prescribed one or more diabetes medications are maintaining blood sugar levels within the …

Special Spotlight On Diabetes Insulins: Invokana (canagliflozin)

Medically reviewed by Zara Risoldi Cochrane, PharmD, MS, FASCP on April 24, 2019 — Written by Victor Nguyen, PharmD, MS. Republished with …

Eli Lilly and Company’s Lower-Priced Insulin Now Available

Eli Lilly and Company announced its generic, half-priced version of Humalog insulin is now available for order in pharmacies across the U.S. The …

FDA Gives INVOKANA® Priority Review to Treat Chronic Kidney Disease in Patients with T2D

Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the …

Special Spotlight On Diabetes Insulins: Jardiance (empagliflozin)

Medically reviewed by Catherine C. Peng, PharmD, BCPS on 4/17/19. Written by Lindsay Slowiczek, PharmD. Republished with permission from Healthline. …